BURLINGTON, Ontario--(BUSINESS WIRE)--$ANRG #ANRG--Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) today announced its financial results for the three- and six-month periods ended June 30, 2022 (“Q2 2022”), as well as the filing of its
WINNIPEG, Manitoba--(BUSINESS WIRE)--$FDGE #AgTech--Farmers Edge Inc. ("Farmers Edge" or the "Company") (TSX: FDGE) announced today that the Company has filed articles of continuance to continue out of the jurisdiction of The Corporations Act (Manitoba) a
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, is pleased to announce the voting results for each of the mat
H1 2022 revenue increased to ~$15.0 million, up 604% from H1 2021 and 117% from H2 2021, driven by House of Brands Gross Profit increased to ~$7.0 million, up 547% compared to H1 2021 and 363% compared to H2 2021 Company reaffirms its 2022 revenue g
VANCOUVER, British Columbia--(BUSINESS WIRE)--#education--REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) announces it has signed a licensing partnership agreement with Awakn Life Scienc
Personalis’ NeXT Personal™ liquid biopsy assay will be deployed in study collaboration MENLO PARK, Calif. & VANCOUVER, British Columbia--(BUSINESS WIRE)--Personalis, Inc. has announced a collaboration with BC Cancer to deploy a personalized liquid bi
- Blexten Canadian Prescriptions Increased 17% Year-Over-Year - - Suvexx Canadian Prescriptions Increased 85% Year-Over-Year - - Plans to Wind-Down Manufacturing Facility in Varennes, Québec - Miravo to Host Conference Call/Audio Webcast August 15th
- Phase II acute pain program to initiate in September - Ended quarter with $50 million in cash and equivalents, providing over two years of runway TORONTO--(BUSINESS WIRE)--$ATBPF--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage com
Investment Tax Credits will support further development of biogas production infrastructure BURLINGTON, Ontario--(BUSINESS WIRE)--The U.S. House of Representatives, last Friday, passed the Inflation Reduction Act of 2022, which provides for historic inve
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX:APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced its financial and
Seven Oaks Capital Corp.is pleased to announce that it has entered into a binding letter agreement dated January 29, 2023 (the "Definitive Agreement") with Rimon Hedge Funds Ltd.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.